特定非営利活動法人日本肺癌学会 - オンラインジャーナル

検索結果

結果：4件
（1から4までを表示します．）

Japan-Korea Joint Symposium
Preoperative treatment with immune checkpoint inhibitors―Multidisciplinary approach―

座長：Isamu Okamoto¹, Tae Jung Kim²（Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University¹, Department of Hospital Pathology, Yeouido St. Mary's hospital, The Catholic University of Korea²）

JS-1．Preanalytic efforts for optimal pre- and post-operative PD-L1 assessment in NSCLC samples: *Tae-Jung Kim
Department of Hospital Pathology, Yeouido St. Mary's hospital, The Catholic University of Korea

第63回日本肺癌学会学術集会　2022年12月開催

Japan-Korea Joint Symposium
Preoperative treatment with immune checkpoint inhibitors―Multidisciplinary approach―

JS-2．Updates in perioperative treatments and early efficacy endpoints in the era of immune checkpoint inhibitors: *Hidehito Horinouchi
Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan

第63回日本肺癌学会学術集会　2022年12月開催

Japan-Korea Joint Symposium
Preoperative treatment with immune checkpoint inhibitors―Multidisciplinary approach―

JS-3．Role of surgery for locally advanced NSCLC in the new era of preoperative treatment with immune checkpoint inhibitors: *Shunichi Watanabe
Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan

第63回日本肺癌学会学術集会　2022年12月開催

Japan-Korea Joint Symposium
Preoperative treatment with immune checkpoint inhibitors―Multidisciplinary approach―

JS-4．Patients management during and after neoadjuvant immunotherapy in NSCLC: *Seung Hyeun Lee^1,2
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Kyung Hee University Hospital¹；Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, South Korea²

第63回日本肺癌学会学術集会　2022年12月開催